Isatis indigotica: a review of phytochemistry, pharmacological activities and clinical applications

Author:

Chen Qiong12,Lan Hai-Yue1,Peng Wei2,Rahman Khalid3,Liu Qing-Chun4,Luan Xin1,Zhang Hong12ORCID

Affiliation:

1. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China

2. School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China

3. School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, England, UK

4. Department of Medicine, Chengdu Brilliant Pharmaceutical Co. Ltd. , Chengdu, China

Abstract

Abstract Objectives Isatis indigotica Fort. (I. indigotica) is an herbaceous plant belonging to Cruciferae family. Its leaf (IIL) and root (IIR) are commonly used in traditional Chinese medicines (TCMs) with good clinical efficacies such as clearing away heat and detoxification, cooling blood and reducing swelling. This review aimed to provide a systematic summary on the phytochemistry, pharmacology and clinical applications of I. indigotica. Key findings This plant contains alkaloids, organic acids, flavonoids, lignans, nucleosides, amino acids, and steroids. Previous pharmacological researches indicated that I. indigotica possesses promising antivirus, antibacterial, immunoregulatory, anti-inflammation, and cholagogic effects. Importantly, it can inhibit various viruses, such as influenza, hepatitis B, mumps, herpes simplex, cytomegalovirus, and coxsachievirus. Clinically, it is frequently used to treat various viral diseases like viral influenza, parotitis and viral hepatitis. Consequently, I. indigotica may be beneficial for the prevention and treatment of coronavirus disease 2019 (COVID-19). Summary This paper reviewed the chemical constituents, pharmacological effects and clinical applications of I. indigotica which may guide further research and application of this plant.

Funder

National Natural Science Foundation of China

National Key Subject of Drug Innovation

National key R & D program for key research project of modernization of traditional Chinese medicine

Xinglin Scholar Discipline Promotion Talent Program of Chengdu University of Traditional Chinese Medicine

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

Reference118 articles.

1. Study on the effective components of Isatis indigotica root, stem and leaf;Liang;Guangzhou Chem,2016

2. Pharmaceutical research on the medicinal parts of Isatis indigotica and Indigo indigotica[D];Pei;Heilongjiang Univ Trad Chin Med,2007

3. Selection of reference genes for the quantitative real-time PCR normalization of gene expression in Isatis indigotica fortune;Qu;BMC Mol Biol,2019

4. Extraction and content comparison of indigo and indirubin in Isatis indigotica root, stem and leaf;Li;Guangdong Chem,2016

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3